Uclpartners Annual Report 2015/16
Total Page:16
File Type:pdf, Size:1020Kb
UCLPartners Annual Report 2015/16 Contents Chair’s statement 06 Managing director’s statement 07 Directors’ report 08 • Business review 09 • Introducing UCLPartners – An Academic Health Science Partnership 10 • UCLPartners Academic Health Science Centre 12 • North Thames NHS Genomic Medicine Centre 15 • NIHR Clinical Research Network North Thames 16 • UCLPartners Academic Health Science Network 18 • Improvement, quality and leadership development 26 • System transformation and population health 30 • NIHR Collaboration for Leadership in Applied Health Research and Care North Thames 36 • Education Lead Provider 39 • Corporate governance 40 • Financial report 44 • Auditor’s statement 48 Appendix 1 – Details of partnership members 49 Appendix 2 – Financial statements 50 The information contained in this report was correct at the time of publishing (April 2016) UCLPartners Annual Report 2015/16 • Contents 03 2015/16 Achievements through partnership Discovery science 1. Dementia research: 2. Proposed Institute 3. The London Project 4. The Zayed Centre 5. Institute of created a partnership of Mental Health: to Cure Blindness: for Research into Immunity and with the retail industry supported a proposal first embryonic stem Rare Disease in Transplantation: to provide funding for to create new joint cell surgery was Children: supporting developing new dementia research. institutes for mental conducted to reverse the development of diagnostic tools and Join Dementia health and for eyes vision loss caused by the largest centre therapies for immune- Research is increasing and vision, co-located age-related macular for paediatric health related diseases the number of people within a single degeneration research in Europe Partners: Universities, participating in campus Partners: Universities, Partners: Universities, NHS, charity, industry dementia research Partners: Universities, NHS, industry NHS, charity, industry studies NHS, industry Partners: Universities, NHS, industry, philanthropy, AHSN Network, charities Innovation into practice 1. NHS Innovation 2. Care City: 3. DigitalHealth. 4. Genomic Medicine 5. Improving Accelerator: supporting the London: building the Centre: at the current outcomes for patients created a national creation of a centre ecosystem, market rate, the North with atrial fibrillation: platform supporting for healthy ageing, and evidence base for Thames NHS Genomic driven improvement entrepreneurs to innovation, research digital health across Medicine Centre is and research across accelerate the use and education London recruiting over one the atrial fibrillation of high impact Partners: NHS Partners: London quarter of all rare pathway including innovations across the (acute, primary care, AHSNs and AHSCs, disease genomes in the increased detection, NHS for patient benefit community), industry, MedCity, Greater country anticoagulation, and Partners: NHS England, councils, voluntary London Authority, NHS Partners: NHS (acute), medicines optimisation Health Foundation, sector, innovators, England, industry, NHS universities, National Partners: Pan-London AHSNs, industry universities Institute for Health AHSNs, NHS industry, (global), universities Research (NIHR) policy makers, (global) universities Population health and place-based care 1. Essex Success 2. The Newham 3. i-THRIVE: 4. National digital 5. Barts Heart Regime: supporting partnership: supporting a major maturity assessment: Centre: developing whole health system supporting service transformation commissioned by system leadership for and social care partnership solutions for child and NHS England to cardiovascular care transformation in to a range of health adolescent mental deliver a national and research south and mid Essex issues in Newham health services digital maturity scan, Partners: NHS Partners: NHS (acute, Partners: Voluntary Partners: Charities, completed by 99% of England, NHS, primary care, out-of- sector, NHS (acute, NHS (acute, mental the NHS universities, charity hospital care) across mental health, health, primary Partners: NHS (acute, south and mid Essex, primary care), schools, care, NHS England), community, mental councils, regulators, universities CLAHRC, universities health, ambulance patient groups (UK and USA) services, NHS England), industry UCLPartners Annual Report 2015/16 • Achievements through partnership 04 These pages provide a snapshot of achievements delivered in partnership, highlighting the range of partners involved. Every area that supports healthcare delivery works in partnership with patients and/or patient groups and this is fundamental to UCLPartners’ approach. 6. Bloomsbury 7. Africa Centre: 8. Cardiovascular 9. Cancer Academic 10. Cancer Research Research Institute: submitted major Academic Medical Medical Centre: UK Major Centre: planning permission funding bid for Centre: delivering a building on scientific developed a granted for a new research into joint cardiovascular breakthroughs and partnership proposal research institute infectious disease devices centre to supporting spin- to deliver world- to undertake world- and antimicrobial focus on prevention out companies in leading research, leading research into resistance and novel therapies immunotherapy improved patient infectious disease Partners: Universities, Partners: Universities, Partners: Universities, care and greater local Partners: Universities, charity, industry NHS, industry NHS, industry engagement NHS, industry Partners: Universities, NHS, charity, industry 6. Increasing 7. Quintiles Prime Site: 8. Neuroresponse: 9. Multiple sclerosis: 10. Proton Beam improvement UCLPartners has the adapting and scaling supporting the Therapy: partnership capability: created a highest recruitment of a nurse led, 24/7 new introduction of new support has enabled cohort of improvement patients to Quintiles model of care for long pharmacological and approval of a new fellows to embed trials in the world, term neurological digital therapies for a world-class facility at improvement across increasing patient conditions population of 10,000 UCLH for the treatment the partnership to access to innovative Partners: NHS (acute, patients with multiple of complex and hard- delivering better treatments and clinical mental health, 111), sclerosis to-treat cancers in results for patients and trials voluntary sector, Partners: Universities, children and adults populations. Partners: Industry, NHS industry, Yorkshire and NHS, industry, NIHR, Partners: Universities, Partners: Universities, (acute), NIHR Humber AHSN charities NHS NHS (acute, community, mental health), councils 6. National Cancer 7. Dementia 8. Supporting 9. London devolution 10. Host pan-London Vanguard: supporting awareness training: sustainability and pilots: supporting neonatal operational national initiatives helping to reduce transformation plans: new ways of working delivery network: to improve early the variation in care sharing knowledge in partnership to supporting improved diagnosis and provided for people across UCLPartners to transform health and outcomes for prevention of cancer with dementia by reduce costs, increase social care premature babies through forming part training more than pace and scale of Partners: NHS (acute Partners: NHS (London of the national cancer 40,000 staff change and primary care), acute and ambulance vanguard Partners: NHS (acute, Partners: NHS councils trusts, NHS England) Partners: NHS (local community, mental England, STPs across and national partners), health) UCLPartners universities UCLPartners Annual Report 2015/16 • Achievements through partnership 05 Chair’s statement UCLPartners has continued this year to make an important contribution to transforming the health of our population, both within the local partnership and through our national connections and influence. The changing and challenging environment in the delivery of health and social care has not altered the company’s determination to deliver outstanding results on behalf of the partners. During the year, UCLPartners has reviewed its model, and rather than focusing on patient pathways for specific diseases, the company has adopted an approach to place-based care, building on existing expertise to support improvements for whole populations across the partnership. This approach - linking up organisations in the health and care system to ensure that high quality care is delivered effectively and efficiently - is wholeheartedly supported by the Board and endorsed by national leaders. Championing innovation and its translation into practice continues to be a key role for UCLPartners, and we have been privileged to host and lead the NHS Innovation Accelerator in partnership with NHS England, the Health Foundation and the country’s Academic Health Science Networks. Following a rigorous recruitment process, 17 top innovators from across the UK and overseas are now supported by the programme to introduce their innovations into the NHS at scale and pace. In just the first nine months, these innovative new products and services have benefited over three million patients across 14% of the NHS and have generated over £8m in additional external income. This is an outstanding achievement and demonstrates UCLPartners’ expertise and knowledge in this field. We will build on this programme as a key part of our ongoing commitment to innovation. This year we have had success in broadening our engagement strategy to involve more colleagues from the social care sector, whilst continuing to engage with and support partners across